78 related articles for article (PubMed ID: 2965871)
1. Degradation of [125I]-atrial natriuretic peptide by a soluble metallopeptidase isolated from rat ventricular myocytes.
Rugg EL; Aiton JF; Cramb G
Biochem Biophys Res Commun; 1988 Apr; 152(1):294-300. PubMed ID: 2965871
[TBL] [Abstract][Full Text] [Related]
2. Characterization of atrial natriuretic peptide degradation by cell-surface peptidase activity on endothelial cells.
Frost SJ; Whitson PA
J Cell Biochem; 1993 Jun; 52(2):227-36. PubMed ID: 8366138
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide binds to ANP-R1 receptors in neuroblastoma cells or is degraded extracellularly at the Ser-Phe bond.
Delporte C; Poloczek P; Tastenoy M; Winand J; Christophe J
Eur J Pharmacol; 1992 Nov; 227(3):247-56. PubMed ID: 1335413
[TBL] [Abstract][Full Text] [Related]
4. Respective roles of kallikrein and endopeptidase 24.11 in the metabolic pathway of atrial natriuretic peptide in the rat.
Vanneste Y; Pauwels S; Lambotte L; Michel A; Dimaline R; Deschodt-Lanckman M
Biochem J; 1990 Aug; 269(3):801-6. PubMed ID: 1697165
[TBL] [Abstract][Full Text] [Related]
5. A liver metalloendopeptidase which degrades the circulating hypotensive peptide hormones bradykinin and atrial natriuretic peptide.
Carvalho KM; Nava RA; França MS; Medeiros MA; Camarão GC; Juliano L
Braz J Med Biol Res; 1999 Jan; 32(1):51-4. PubMed ID: 10347768
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of binding sites for [125I] ANP in the myocardium but not in Purkinje fibers of the bovine heart.
Hansson M; Barroso C; Gulbenkian S; Forsgren S
Cell Tissue Res; 1997 Dec; 290(3):669-73. PubMed ID: 9369543
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel, high-molecular weight, acidic, endothelin-1 inactivating metalloendopeptidase from the rat kidney.
Janas J; Sitkiewicz D; Warnawin K; Janas RM
J Hypertens; 1994 Oct; 12(10):1155-62. PubMed ID: 7836731
[TBL] [Abstract][Full Text] [Related]
8. Effect of phorbol ester on the release of atrial natriuretic peptide from the hypertrophied rat myocardium.
Kinnunen P; Taskinen T; Järvinen M; Ruskoaho H
Br J Pharmacol; 1991 Feb; 102(2):453-61. PubMed ID: 1826618
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide degradation by CPA47 cells: evidence for a divalent cation-independent cell-surface proteolytic activity.
Frost SJ; Chen YM; Whitson PA
Biochim Biophys Acta; 1992 Nov; 1112(1):45-51. PubMed ID: 1420268
[TBL] [Abstract][Full Text] [Related]
10. Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action.
Sybertz EJ; Chiu PJ; Watkins RW; Vemulapalli S
Can J Physiol Pharmacol; 1991 Oct; 69(10):1628-35. PubMed ID: 1838029
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching.
Kinnunen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1993 May; 132(5):1961-70. PubMed ID: 8477647
[TBL] [Abstract][Full Text] [Related]
12. Distribution and inhibition of neutral metalloendopeptidase (NEP) (EC 3.4.24.11), the major degradative enzyme for atrial natriuretic peptide, in the rat kidney.
Kanazawa M; Johnston CI
Clin Exp Pharmacol Physiol; 1991 Jun; 18(6):449-53. PubMed ID: 1833101
[TBL] [Abstract][Full Text] [Related]
13. Partial characterization of a metalloendopeptidase activity produced by cultured endothelial cells that removes the COOH-terminal tripeptide from 125I-atrial natriuretic factor.
Johnson GR; Foster CJ
Biochem Biophys Res Commun; 1990 Feb; 167(1):110-6. PubMed ID: 2138018
[TBL] [Abstract][Full Text] [Related]
14. Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney.
Sonnenberg JL; Sakane Y; Jeng AY; Koehn JA; Ansell JA; Wennogle LP; Ghai RD
Peptides; 1988; 9(1):173-80. PubMed ID: 2966343
[TBL] [Abstract][Full Text] [Related]
15. Release of atrial natriuretic peptide from rat myocardium in vitro: effect of minoxidil-induced hypertrophy.
Kinnunen P; Taskinen T; Leppäluoto J; Ruskoaho H
Br J Pharmacol; 1990 Apr; 99(4):701-8. PubMed ID: 2141796
[TBL] [Abstract][Full Text] [Related]
16. Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor.
Kanazawa M; Casley DJ; Sybertz EJ; Haslanger MF; Johnston CI
J Pharmacol Exp Ther; 1992 Jun; 261(3):1231-7. PubMed ID: 1534841
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide and its messenger ribonucleic acid in overloaded and overload-released ventricles of rat.
Gu J; D'Andrea M; Seethapathy M
Endocrinology; 1989 Oct; 125(4):2066-74. PubMed ID: 2529116
[TBL] [Abstract][Full Text] [Related]
18. The conversion of atrial natriuretic peptide (ANP)-(1-126) to ANP-(99-126) by rat serum: contribution to ANP cleavage in isolated perfused rat hearts.
Gibson TR; Shields PP; Glembotski CC
Endocrinology; 1987 Feb; 120(2):764-72. PubMed ID: 2948815
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide in plasma, atria, ventricles, and hypothalamus of Long-Evans and vasopressin-deficient Brattleboro rats.
Ruskoaho H; Taskinen T; Pesonen A; Vuolteenaho O; Leppäluoto J; Tuomisto L
Endocrinology; 1989 May; 124(5):2595-603. PubMed ID: 2523304
[TBL] [Abstract][Full Text] [Related]
20. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
